- Home
- KALA vs LUCD Comparison
KALA vs LUCD Comparison
Compare KALA & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- LUCD
- Stock Information
- Founded
- KALA 2009
- LUCD 2018
- Country
- KALA United States
- LUCD United States
- Employees
- KALA N/A
- LUCD N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KALA Health Care
- LUCD Health Care
- Exchange
- KALA Nasdaq
- LUCD Nasdaq
- Market Cap
- KALA 32.0M
- LUCD 38.4M
- IPO Year
- KALA 2017
- LUCD 2021
- Fundamental
- Price
- KALA $6.77
- LUCD $1.00
- Analyst Decision
- KALA Strong Buy
- LUCD Strong Buy
- Analyst Count
- KALA 2
- LUCD 4
- Target Price
- KALA $16.50
- LUCD $3.94
- AVG Volume (30 Days)
- KALA 36.4K
- LUCD 445.5K
- Earning Date
- KALA 11-12-2024
- LUCD 11-13-2024
- Dividend Yield
- KALA N/A
- LUCD N/A
- EPS Growth
- KALA N/A
- LUCD N/A
- EPS
- KALA N/A
- LUCD N/A
- Revenue
- KALA N/A
- LUCD $4,189,000.00
- Revenue This Year
- KALA N/A
- LUCD $88.47
- Revenue Next Year
- KALA N/A
- LUCD $238.94
- P/E Ratio
- KALA N/A
- LUCD N/A
- Revenue Growth
- KALA N/A
- LUCD 179.27
- 52 Week Low
- KALA $4.21
- LUCD $0.63
- 52 Week High
- KALA $10.97
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- KALA 53.32
- LUCD 62.41
- Support Level
- KALA $6.65
- LUCD $0.97
- Resistance Level
- KALA $7.85
- LUCD $1.12
- Average True Range (ATR)
- KALA 0.36
- LUCD 0.07
- MACD
- KALA -0.02
- LUCD 0.01
- Stochastic Oscillator
- KALA 7.43
- LUCD 56.71
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.